The genetic basis of brugada syndrome: A mutation update

Human Mutation

Volumn 30, Issue 9, 2009, Pages 1256-1266

  Hedley, Paula L ^a,c   Jørgensen, Poul ^a,b   Schlamowitz, Sarah ^a   Moolman Smook, Johanna ^c   Kanters, Jørgen K ^d   Corfield, Valerie A ^c   Christiansen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Arrhythmia; Cardiac repolarization; Ion channel; Sudden death; Syncope

Indexed keywords

CALCIUM ION; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE 1; ION CHANNEL; POTASSIUM CHANNEL; SODIUM ION; UNCLASSIFIED DRUG;

ALPHA CHAIN; AUTOSOMAL DOMINANT INHERITANCE; BETA CHAIN; BRUGADA SYNDROME; CACNA1C GENE; CACNB2 GENE; CALCIUM CURRENT; ELECTROCARDIOGRAM; FAMILY; GENE; GENE MUTATION; GENETICS; GPD1L GENE; HEART; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; KCNE3 GENE; LOSS OF FUNCTION MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK; SCN1B GENE; SCN3B GENE; SCN5A GENE; SHORT QT SYNDROME; ST SEGMENT ELEVATION; SUDDEN DEATH;

BRUGADA SYNDROME; CALCIUM CHANNELS, L-TYPE; HUMANS; MUTATION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; SODIUM CHANNELS;

SYNCOPE;

EID: 69549091764     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.21066     Document Type: Review

References (175)

1. Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptacek LJ, Goldstein SA. 2001a. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104:217-231. (Pubitemid 32174838)
2. Abbott GW, Goldstein SA, Sesti F. 2001b. Do all voltage-gated potassium channels use MiRPs? Circ Res 88:981-983.
3. Abbott GW, Goldstein SA. 2002. Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanism. FASEB J 16:390-400.
4. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA. 1999. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97:175-187. (Pubitemid 129746810)
5. Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, Keating MT, Jones G, Chadha M, Burrow CR, Stephens JC, Xu C, Judson R, Curran ME. 2004. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 1:600-607. (Pubitemid 39462721)
6. Akai J, Makita N, Sakurada H, Shirai N, Ueda K, Kitabatake A, Nakazawa K, Kimura A, Hiraoka M. 2000. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett 479:29-34. (Pubitemid 30625253)
7. Alings M, Wilde A. 1999. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. Circulation 99:666-673.
8. 2+ channels expressed in Xenopus oocytes. Pflugers Arch 436:238-247.
9. Amin AS, Verkerk AO, Bhuiyan ZA, Wilde AA, Tan HL. 2005. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na1 channel does not affect ion selectivity properties. Acta Physiol Scand 185:291-301.
10. Antzelevitch C. 1998. The Brugada syndrome. J Cardiovasc Electrophysiol 9:513-516.
11. Antzelevitch C. 2001. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 12:268-272. (Pubitemid 32171521)
12. Antzelevitch C. 2005. Cardiac repolarization. The long and short of it. Europace 7(Suppl 2):3-9.
13. Antzelevitch C, Brugada R. 2002. Fever and Brugada syndrome. Pacing Clin Electrophysiol 25:1537-1539.
14. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, Lemarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. 2005. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2:429-440. (Pubitemid 40439292)
15. Antzelevitch C, Brugada P, Brugada J, Brugada R, Shimizu W, Gussak I, Perez Riera AR. 2002. Brugada syndrome: a decade of progress. Circ Res 91:1114-1118.
16. Antzelevitch C, Brugada P, Brugada J, Brugada R, Towbin JA, Nademanee K. 2003. Brugada syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol 41:1665-1671. (Pubitemid 36584232)
17. Antzelevitch C, Nof E. 2008. Brugada syndrome: recent advances and controversies. Curr Cardiol Rep 10:376-383.
18. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros Jr EP, Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu LF, Haissaguerre M, Schimpf R, Borggrefe M, Wolpert C. 2007. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115:442-449. (Pubitemid 46184195)
19. Araki T, Konno T, Itoh H, Ino H, Shimizu M. 2003. Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia. Circ J 67:93-95. (Pubitemid 36119628)
20. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George Jr AL, Schwartz PJ. 2007. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 115:361-367. (Pubitemid 46148510)
21. Balser JR. 2001. The cardiac sodium channel: gating function and molecular pharmacology. J Mol Cell Cardiol 33:599-613.
22. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, Rowland E, Jeffery S, McKenna WJ. 2008. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J 29:1670-1680. (Pubitemid 351957547)
23. Belhassen B, Glick A, Viskin S. 2004. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 110:1731-1737. (Pubitemid 39299213)
24. Bendahhou S, Marionneau C, Haurogne K, Larroque MM, Derand R, Szuts V, Escande D, Demolombe S, Barhanin J. 2005. In vitro molecular interactions and distribution of KCNE family with KCNQ1 in the human heart. Cardiovasc Res 67:529-538.
25. Bers DM. 2001. Excitation-contraction coupling and cardiac contractile force. Dordrecht, The Netherlands: Kluwer Academic Publishers.
26. Bers DM. 2004. Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 37:417-429. (Pubitemid 38953370)
27. Bezzina C, Veldkamp MW, van den Berg MP, Postma AV, Rook MB, Viersma JW, van Langen IM, Tan-Sindhunata G, Bink-Boelkens MT, van der Hout AH, Mannens MM, Wilde AA. 1999. A single Na(1) channel mutation causing both long-QT and Brugada syndromes. Circ Res 85:1206-1213. (Pubitemid 30430627)
28. Bezzina CR, Rook MB, Groenewegen WA, Herfst LJ, van derWal AC, Lam J, Jongsma HJ, Wilde AA, Mannens MM. 2003. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 92:159-168.
29. Blangy H, Sadoul N, Coutelour JM, Rebmann JP, Joseph M, Scherrer C, de CC, Magnin-Poull I, Aliot E. 2005. [Prevalence of Brugada syndrome among 35,309 inhabitants of Lorraine screened at a preventive medicine centre]. Arch Mal Coeur Vaiss 98:175-180.
30. Bozkurt A, Yas D, Seydaoglu G, Acarturk E. 2006. Frequency of Brugada-type ECG pattern (Brugada sign) in Southern Turkey. Int Heart J 47:541-547. (Pubitemid 44463659)
31. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. 2002a. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 105:73-78. (Pubitemid 34049145)
32. Brugada J, Brugada R, Brugada P. 2000a. Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death. J Electrocardiol 33(Suppl):41-47. (Pubitemid 32167282)
33. Brugada J, Brugada R, Brugada P. 2003. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 108:3092-3096. (Pubitemid 38031797)
34. Brugada P, Brugada J. 1992. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20:1391-1396.
35. Brugada P, Brugada R, Brugada J. 2000b. The Brugada syndrome. Curr Cardiol Rep 2:507-514.
36. Brugada P, Brugada J, Brugada R. 2002b. The Brugada syndrome. Card Electrophysiol Rev 6:45-48.
37. Carlson MD, White RD, Trohman RG, Adler LP, Biblo LA, Merkatz KA, Waldo AL. 1994. Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J Am Coll Cardiol 24:720-727.
38. Casini S, Tan HL, Bhuiyan ZA, Bezzina CR, Barnett P, Cerbai E, Mugelli A, Wilde AA, Veldkamp MW. 2007. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation. Cardiovasc Res 76:418-429. (Pubitemid 350007464)
39. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. 2005. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411-425.
40. Cha A, Ruben PC, George Jr AL, Fujimoto E, Bezanilla F. 1999. Voltage sensors in domains III and IV, but not I and II, are immobilized by Na1channel fast inactivation. Neuron 22:73-87. (Pubitemid 29070095)
41. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q. 1998. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392:293-296. (Pubitemid 28155103)
42. Chung SK, MacCormick JM, McCulley CH, Crawford J, Eddy CA, Mitchell EA, Shelling AN, French JK, Skinner JR, Rees MI. 2007. Long QT and Brugada syndrome gene mutations in New Zealand. Heart Rhythm 4:1306-1314. (Pubitemid 47457201)
43. Cordeiro JM, Barajas-Martinez H, Hong K, Burashnikov E, Pfeiffer R, Orsino AM, Wu YS, Hu D, Brugada J, Brugada P, Antzelevitch C, Dumaine R, Brugada R. 2006. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. Circulation 114:2026-2033. (Pubitemid 44706878)
44. Cordeiro JM, Marieb M, Pfeiffer R, Calloe K, Burashnikov E, Antzelevitch C. 2009. Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. J Mol Cell Cardiol 46:695-703.
45. Cornet V, Bichet D, Sandoz G, Marty I, Brocard J, Bourinet E, Mori Y, Villaz M, De WM. 2002. Multiple determinants in voltage-dependent P/Q calcium channels control their retention in the endoplasmic reticulum. Eur J Neurosci 16:883-895.
46. Darbar D, Kannankeril PJ, Donahue BS, Kucera G, Stubblefield T, Haines JL, George Jr AL, Roden DM. 2008. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 117:1927-1935. (Pubitemid 351543468)
47. Delpon E, Cordeiro JM, Nunez L, Thomsen PE, Guerchicoff A, Pollevick GD, Wu Y, Kanters JK, Larsen CT, Burashnikov E, Christiansen M, Antzelevitch C. 2008. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 1:209-218.
48. Deschenes I, Baroudi G, Berthet M, Barde I, Chalvidan T, Denjoy I, Guicheney P, Chahine M. 2000. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Cardiovasc Res 46:55-65. (Pubitemid 30155945)
49. Dias da Silva MR, Cerutti JM, Arnaldi LA, Maciel RM. 2002. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab 87:4881-4884.
50. Di Diego JM, Cordeiro JM, Goodrow RJ, Fish JM, Zygmunt AC, Perez GJ, Scornik FS, Antzelevitch C. 2002. Circulation 106:2004-2011.
51. Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV, Brugada J, Brugada R, Antzelevitch C. 1999. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 85:803-809. (Pubitemid 29504155)
52. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R, Wichter T, Boisseau P, Heinecke A, Breithardt G, Borggrefe M, Lemarec H, Bocker D, Wilde AA. 2005. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 111:257-263. (Pubitemid 40165330)
53. Eleftheriadis D, Panagiotis V, Eleftheriadis N. 2004. Recurrent syncopic episodes as a consequence of combined Brugada syndrome and paroxysmal atrial fibrillation. Which is the therapy of choice? Int J Cardiol 94:319-320.
54. Fish JM, Antzelevtich C. 2003. Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes. J Electrocardiol 36(Suppl):173-179.
55. Fozzard HA, Hanck DA. 1996. Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms. Physiol Rev 76:887-926.
56. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I, Sanna T, Bellocci F, Russo MA. 2005. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 112:3680-3687. (Pubitemid 43739507)
57. Gellens ME, George Jr AL, Chen LQ, Chahine M, Horn R, Barchi RL, Kallen RG. 1992. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci USA 89:554-558.
58. George Jr AL, Varkony TA, Drabkin HA, Han J, Knops JF, Finley WH, Brown GB, Ward DC, Haas M. 1995. Assignment of the human heart tetrodotoxin-resistant voltage-gated Na1 channel alpha-subunit gene (SCN5A) to band 3p21. Cytogenet Cell Genet 68:67-70. (Pubitemid 24335383)
59. Gervacio-Domingo G, Isidro J, Tirona J, Gabriel E, David G, Amarillo ML, Morales D, Dans A. 2008. The Brugada type 1 electrocardiographic pattern is common among Filipinos. J Clin Epidemiol 61:1067-1072.
60. Goldgran-Toledano D, Sideris G, Kevorkian JP. 2002. Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 346:1591-1592. (Pubitemid 34755707)
61. Grandi E, Puglisi JL, Wagner S, Maier LS, Severi S, Bers DM. 2007. Simulation of Cacalmodulin- dependent protein kinase II on rabbit ventricular myocyte ion currents and action potentials. Biophys J 93:3835-3847. (Pubitemid 350223802)
62. Grunnet M, Rasmussen HB, Hay-Schmidt A, Rosenstierne M, Klaerke DA, Olesen SP, Jespersen T. 2003. KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels. Biophys J 85:1525-1537. (Pubitemid 37052239)
63. Hofman-Bang J, Behr ER, Hedley P, Tfelt-Hansen J, Kanters JK, Haunsoe S, McKenna WJ, Christiansen M. 2006. High-efficiency multiplex capillary electrophoresis single strand conformation polymorphism (multi-CE-SSCP) mutation screening of SCN5A: a rapid genetic approach to cardiac arrhythmia. Clin Genet 69:504-511. (Pubitemid 43757100)
64. Hong K, Berruezo-Sanchez A, Poungvarin N, Oliva A, Vatta M, Brugada J, Brugada P, Towbin JA, Dumaine R, Pinero-Galvez C, Antzelevitch C, Brugada R. 2004a. Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A: female predominance in the signs and symptoms of the disease. J Cardiovasc Electrophysiol 15:64-69. (Pubitemid 38147221)
65. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD, Guerchichoff A, Matsuo K, Burashnikov E, Dumaine R, Towbin JA, Nesterenko V, Brugada P, Antzelevitch C, Brugada R. 2004b. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 110:3023-3027. (Pubitemid 39491993)
66. Hong K, Guerchicoff A, Pollevick GD, Oliva A, Dumaine R, De ZM, Burashnikov E, Wu YS, Brugada J, Brugada P, Brugada R. 2005. Cryptic 50 splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol 38:555-560. (Pubitemid 40461819)
67. Hu D, Martinez HB, Burashnikov E, Springer M, Wu Y, Varro A, Pfeiffer R, Koopmann TT, Cordeiro JM, Guerchicoff A, Pollevick GD, Antzelevitch C. 2009. A mutation in the b3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet (in press).
68. Itoh H, Shimizu M, Mabuchi H, Imoto K. 2005. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A. J Cardiovasc Electrophysiol 16:378-383. (Pubitemid 40504503)
69. Ito H, Yano K, Chen R, He Q, Curb JD. 2006. The prevalence and prognosis of a Brugada-type electrocardiogram in a population of middle-aged Japanese-American men with follow-up of three decades. Am J Med Sci 331:25-29. (Pubitemid 43177512)
70. Jespersgaard C, Larsen LA, Baba S, Kukita Y, Tahira T, Christiansen M, Vuust J, Hayashi K, Andersen PS. 2006. Optimization of capillary array electrophoresis single-strand conformation polymorphism analysis for routine molecular diagnostics. Electrophoresis 27:3816-3822. (Pubitemid 44608400)
71. Jurkat-Rott K, Lehmann-Horn F. 2004. Periodic paralysis mutation MiRP2-R83H in controls: interpretations and general recommendation. Neurology 62:1012-1101. (Pubitemid 38435802)
72. Kawamura M, Ozawa T, Yao T, Ashihara T, Sugimoto Y, Yagi T, Itoh H, Ito M, Makiyama T, Horie M . 2009. Dynamic change in ST-segment and spontaneous occurrence of ventricular fibrillation in Brugada syndrome with a novel nonsense mutation in the SCN5A gene during long-term follow-up. Circ J 73:584-588.
73. Keller DI, Barrane FZ, Gouas L, Martin J, Pilote S, Suarez V, Osswald S, Brink M, Guicheney P, Schwick N, Chahine M. 2005a. A novel nonsense mutation in the SCN5A gene leads to Brugada syndrome and a silent gene mutation carrier state. Can J Cardiol 21:925-931. (Pubitemid 41582313)
74. Keller DI, Huang H, Zhao J, Frank R, Suarez V, Delacretaz E, Brink M, Osswald S, Schwick N, Chahine M. 2006. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation. Cardiovasc Res 70:521-529.
75. Keller DI, Rougier JS, Kucera JP, Benammar N, Fressart V, Guicheney P, Madle A, Fromer M, Schlapfer J, Abriel H. 2005b. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovasc Res 67:510-519. (Pubitemid 41019558)
76. Kontis KJ, Goldin AL. 1997. Sodium channel inactivation is altered by substitution of voltage sensor positive charges. J Gen Physiol 110:403-413.
77. Kontis KJ, Rounaghi A, Goldin AL. 1997. Sodium channel activation gating is affected by substitutions of voltage sensor positive charges in all four domains. J Gen Physiol 110:391-401. (Pubitemid 27431177)
78. Kurita T, Shimizu W, Inagaki M, Suyama K, Taguchi A, Satomi K, Aihara N, Kamakura S, Kobayashi J, Kosakai Y. 2002. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 40:330-334. (Pubitemid 34756296)
79. Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baro I, Moisan JP, Boisseau P, Schott JJ, Escande D, Le MH. 2001. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 104:3081-3086.
80. Lai LP, Su YN, Hsieh FJ, Chiang FT, Juang JM, Liu YB, Ho YL, Chen WJ, Yeh SJ, Wang CC, Ko YL, Wu TJ, Ueng KC, Lei MH, Tsao HM, Chen SA, Lin TK, Wu MH, Lo HM, Huang SK, Lin JL. 2005. Denaturing high-performance liquid chromatography screening of the long QTsyndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms. J Hum Genet 50:490-496.
81. Laitinen-Forsblom PJ, Makynen P, Makynen H, Yli-Mayry S, Virtanen V, Kontula K, Aalto-Setala K. 2006. SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias. J Cardiovasc Electrophysiol 17:480-485.
82. Levy-Nissenbaum E, Eldar M, Wang Q, Lahat H, Belhassen B, Ries L, Friedman E, Pras E. 2001. Genetic analysis of Brugada syndrome in Israel: two novel mutations and possible genetic heterogeneity. Genet Test 5:331-334. (Pubitemid 34258411)
83. Lewis A, McCrossan ZA, Abbott GW. 2004. MinK, MiRP1, and MiRP2 diversify Kv3.1 and Kv3.2 potassium channel gating. J Biol Chem 279:7884-7892. (Pubitemid 38294675)
84. Liang P, Liu WL, Hu DY, Li CL, Tao WH, Li L. 2006. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617]. Zhonghua Xin Xue Guan Bing Za Zhi 34:616-619.
85. Littmann L, Monroe MH, Taylor III L, Brearley Jr WD. 2007a. The hyperkalemic Brugada sign. J Electrocardiol 40:53-59.
86. Littmann L, Taylor III L, Brearley Jr WD. 2007b. ST-segment elevation: a common finding in severe hypercalcemia. J Electrocardiol 40:60-62. (Pubitemid 46001402)
87. London B, Michalec M, Mehdi H, Zhu X, Kerchner L, Sanyal S, Viswanathan PC, Pfahnl AE, Shang LL, Madhusudanan M, Baty CJ, Lagana S, Aleong R, Gutmann R, Ackerman MJ, McNamara DM, Weiss R, Dudley Jr SC. 2007. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na1current and causes inherited arrhythmias. Circulation 116:2260-2268. (Pubitemid 350100331)
88. Lukas A, Antzelevitch C. 1996. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. Cardiovasc Res 32:593-603. (Pubitemid 26288606)
89. Makita N, Behr E, Shimizu W, Horie M, Sunami A, Crotti L, Schulze-Bahr E, Fukuhara S, Mochizuki N, Makiyama T, Itoh H, Christiansen M, McKeown P, Miyamoto K, Kamakura S, Tsutsui H, Schwartz PJ, George Jr AL, Roden DM. 2008. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 118:2219-2229. (Pubitemid 351872340)
90. Makita N, Sasaki K, Groenewegen WA, Yokota T, Yokoshiki H, Murakami T, Tsutsui H. 2005. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2:1128-1134. (Pubitemid 41472165)
91. Makita N, Sloan-Brown K, Weghuis DO, Ropers HH, George Jr AL. 1994. Genomic organization and chromosomal assignment of the human voltage-gated Na(+) channel beta-1 subunit gene (SCN1B). Genomics 23:628-634.
92. Makita N, Sumitomo N, Watanabe I, Tsutsui H. 2007. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope. Heart Rhythm 4:516-519. (Pubitemid 46610397)
93. Makiyama T, Akao M, Tsuji K, Doi T, Ohno S, Takenaka K, Kobori A, Ninomiya T, Yoshida H, Takano M, Makita N, Yanagisawa F, Higashi Y, Takeyama Y, Kita T, Horie M. 2005. High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol 46:2100-2106. (Pubitemid 41713598)
94. Makiyama T, Akao M, Haruna Y, Tsuji K, Doi T, Ohno S, Nishio Y, Kita T, Horie M. 2008a. Mutation analysis of the glycerol-3 phosphate dehydrogenase-1 like (GPD1L) gene in Japanese patients with Brugada syndrome. Circ J 72:1705-1706.
95. Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y, Ohno S, Nishio Y, Tsuji K, Itoh H, Kimura T, Kita T, Horie M. 2008b. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 52:1326-1334.
96. McCrossan ZA, Lewis A, Panaghie G, Jordan PN, Christini DJ, Lerner DJ, Abbott GW. 2003. MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels in mammalian brain. J Neurosci 23:8077-8091. (Pubitemid 37082461)
97. McPhee JC, Ragsdale DS, Scheuer T, Catterall WA. 1998. A critical role for the S4-S5 intracellular loop in domain IV of the sodium channel alpha-subunit in fast inactivation. J Biol Chem 273:1121-1129. (Pubitemid 28049213)
98. Meadows LS, Isom LL. 2005. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes. Cardiovasc Res 67:448-458.
99. Melman YF, Krumerman A, McDonald TV. 2002. A single transmembrane site in the KCNE-encoded proteins controls the specificity of KvLQT1 channel gating. J Biol Chem 277:25187-25194. (Pubitemid 34951825)
100. Meregalli PG, Wilde AA, Tan HL. 2005. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res 67:367-378.
101. Millat G, Chanavat V, Rodriguez-Lafrasse C, Rousson R. 2009. Rapid, sensitive and inexpensive detection of SCN5A genetic variations by high resolution melting analysis. Clin Biochem 42:491-499.
102. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. 1996. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 27:1061-1070. (Pubitemid 26119611)
103. Mizumaki K, Fujiki A, Tsuneda T, Sakabe M, Nishida K, Sugao M, Inoue H. 2004. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J Cardiovasc Electrophysiol 15:667-673. (Pubitemid 38757172)
104. Mizusawa Y, Sakurada H, Nishizaki M, Hiraoka M. 2006. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment. J Cardiovasc Pharmacol 47:359-364. (Pubitemid 44309687)
105. Morgan K, Stevens EB, Shah B, Cox PJ, Dixon AK, Lee K, Pinnock RD, Hughes J, Richardson PJ, Mizuguchi K, Jackson AP. 2000. Beta 3: an additional auxillary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci USA 97:2308-2313. (Pubitemid 30134065)
106. Morin TJ, Kobertz WR. 2008. Counting membrane-embedded KCNE beta-subunits in functioning K+ channel complexes. Proc Natl Acad Sci USA 105:1478-1482.
107. Nademanee K. 1997. Sudden unexplained death syndrome in Southeast Asia. Am J Cardiol 79:10-11. (Pubitemid 27161037)
108. Nademanee K, Veerakul G, Mower M, Likittanasombat K, Krittayapong R, Bhuripanyo K, Sitthisook S, Chaothawee L, Lai MY, Azen SP. 2003. Defibrillator versus beta-blockers for unexplained death in Thailand (DEBUT): a randomized clinical trial. Circulation 107:2221-2226. (Pubitemid 36547216)
109. Nagase T, Seki N, Tanaka A, Ishikawa K, Nomura N. 1995. Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res 2:167-210.
110. Nakajima T, Kurachi Y, Ito H, Takikawa R, Sugimoto T. 1989. Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: mediation by different molecular mechanisms. Circ Res 64:297-303. (Pubitemid 19054026)
111. Nakajo K, Kubo Y. 2007. KCNE1 abd KCNE3 stabilize and/or slow voltage sensing S4 segment of KCNQ1 channel. J Gen Physiol 130:269-281. (Pubitemid 47443289)
112. Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, Bottelli G, Cerrone M, Leonardi S. 2005. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 294:2975-2980. (Pubitemid 41817658)
113. Niimura H, Matsunaga A, Kumagai K, Ohwaki K, Ogawa M, Noguchi H, Yonemura K, Saku K. 2004. Genetic analysis of Brugada syndrome in Western Japan: two novel mutations. Circ J 68:740-746. (Pubitemid 39044954)
114. Ning L, Moss A, Zareba W, Robinson J, Rosero S, Ryan D, Qi M. 2003. Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome. Genet Test 7:249-253. (Pubitemid 37363086)
115. Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y, Smits JF, Flameng W, Clancy CE, Moons L, Vos MA, Dewerchin M, Benndorf K, Collen D, Carmeliet E, Carmeliet P. 2001. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 7:1021-1027. (Pubitemid 32937382)
116. Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ, Horton SC, Rodeheffer RJ, Anderson JL. 2005. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293:447-454.
117. Ortega-Carnicer J, Bertos-Polo J, Gutierrez-Tirado C. 2001. Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion. J Electrocardiol 34:345-349. (Pubitemid 32983257)
118. Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AE, Huang CL, Vandenberg JI, Colledge WH, Grace AA. 2002. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci USA 99:6210-6215. (Pubitemid 34493291)
119. Papavassiliu T, Wolpert C, Fluchter S, Schimpf R, Neff W, Haase KK, Duber C, Borggrefe M. 2004. Magnetic resonance imaging findings in patients with Brugada syndrome. J Cardiovasc Electrophysiol 15:1133-1138. (Pubitemid 39426040)
120. Pastor A, Nunez A, Cantale C, Cosio FG. 2001. Asymptomatic brugada syndrome case unmasked during dimenhydrinate infusion. J Cardiovasc Electrophysiol 12:1192-1194. (Pubitemid 32983529)
121. Petitprez S, Jespersen T, Pruvot E, Keller DI, Corbaz C, Schlapfer J, Abriel H, Kucera JP. 2008. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome. Cardiovasc Res 78:494-504. (Pubitemid 351769757)
122. Pfahnl AE, Viswanathan PC, Weiss R, Shang LL, Sanyal S, Shusterman V, Kornblit C, London B, Dudley Jr SC. 2007. A sodium channel pore mutation causing Brugada syndrome. Heart Rhythm 4:46-53. (Pubitemid 46002625)
123. Pilz B, Luft FC. 2003. Acquired Brugada syndrome. Am J Cardiol 92:771.
124. Priori SG, Napolitano C, Gasparini M, Pappone C, Bella PD, Brignole M, Giordano U, Giovannini T, Menozzi C, Bloise R, Crotti L, Terreni L, Schwartz PJ. 2000a. Clinical and Genetic Heterogeneity of right bundle branch block and ST-segment elevation syndrome. Circulation 102:2509-2515.
125. Priori SG, Napolitano C, Gasparini M, Pappone C, Bella PD, Giordano U, Bloise R, Giustetto C, De NR, Grillo M, Ronchetti E, Faggiano G, Nastoli J. 2002. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105:1342-1347. (Pubitemid 34260426)
126. Priori SG, Napolitano C, Vicentini A. 2003. Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. J Interv Card Electrophysiol 9:93-101. (Pubitemid 37441212)
127. Probst V, Allouis M, Sacher F, Pattier S, Babuty D, Mabo P, Mansourati J, Victor J, Nguyen JM, Schott JJ, Boisseau P, Escande D, Le MH. 2006. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol 17:270-275.
128. Probst V, Denjoy I, Meregalli PG, Amirault JC, Sacher F, Mansourati J, Babuty D, Villain E, Victor J, Schott JJ, Lupoglazoff JM, Mabo P, Veltmann C, Jesel L, Chevalier P, Clur SA, Haissaguerre M, Wolpert C, Le MH, Wilde AA. 2007. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 115:2042-2048. (Pubitemid 46625955)
129. Qin N, D'Andrea MR, Lubin M-L, Shafaee N, Codd EE, Correa AM. 2003. Molecular cloning and functional expression of the human sodium channel b1B subunit, a novel splicing variant of the b1 subunit. Eur J Biochem 270:4762-4770.
130. Rivolta I, Abriel H, Tateyama M, Liu H, Memmi M, Vardas P, Napolitano C, Priori SG, Kass RS. 2001. Inherited Brugada and long QT-3 syndrome mutations of
131. Rossenbacker T, Carroll SJ, Liu H, Kuiperi C, de Ravel TJ, Devriendt K, Carmeliet P, Kass RS, Heidbuchel H. 2004. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death. Heart Rhythm 1:610-615. (Pubitemid 39462723)
132. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O'Neill MD, Garrigue S, Pierre B, Jais P, Pasquie JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haissaguerre M, Mansourati J, Clementy J, Le MH. 2006. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 114:2317-2324.
133. Saffitz JE. 2005. Structural heart disease, SCN5A gene mutations, and Brugada syndrome: a complex menage a trois. Circulation 112:3672-3674.
134. Schroeder BC, Waldegger S, Fehr S, Bleich M, Warth R, Greger R, Jentsch TJ. 2000. A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature 403:196-199. (Pubitemid 30050962)
135. Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, Borggrefe M, Haverkamp W. 2003. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat 21:651-652.
136. Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, Takaki H, Sunagawa K, Kamakura S. 2000. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 11:1320-1329. (Pubitemid 32016854)
137. Shin DJ, Jang Y, Park HY, Lee JE, Yang K, Kim E, Bae Y, Kim J, Kim J, Kim SS, Lee MH, Chahine M, Yoon SK. 2004. Genetic analysis of the cardiac sodium channel gene SCN5A in Koreans with Brugada syndrome. J Hum Genet 49:573-578. (Pubitemid 39506540)
138. Shin DJ, Kim E, Park SB, Jang WC, Bae Y, Han J, Jang Y, Joung B, Lee MH, Kim SS, Huang H, Chahine M, Yoon SK. 2007. A novel mutation in the SCN5A gene is associated with Brugada syndrome. Life Sci 80:716-724. (Pubitemid 46107992)
139. Singer D, Biel M, Lotan I, Flockerzi V, Hofmann F, Dascal N. 1991. The roles of the subunits in the function of the calcium channel. Science 253:1553-1557. (Pubitemid 21917312)
140. Six I, Hermida JS, Huang H, Gouas L, Fressart V, Benammar N, Hainque B, Denjoy I, Chahine M, Guicheney P. 2008. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases. Europace 10:79-85. (Pubitemid 351767268)
141. Smits JP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D, Schulze-Bahr E, Lemarec H, Wilde AA. 2002. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 40:350-356. (Pubitemid 34756299)
142. 2+ channel. Genomics 22:77-87.
143. Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT. 2005. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA 102:8089-8096. (Pubitemid 40800048)
144. Sternberg D, Tabti N, Fournier E, Hainque B, Fontaine B. 2003. Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis. Neurology 61:857-859. (Pubitemid 37174493)
145. Stevens EB, Cox PJ, Shah BS, Dixon AK, Richardson PJ. 2001. Tissue distribution and functional expression of the human voltage gated sodium channel beta 3 subunit. Pflügers Arch 441:481-488.
146. Takahata T, Yasui-Furukori N, Sasaki S, Igarashi T, Okumura K, Munakata A, Tateishi T. 2003. Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects. Life Sci 72:2391-2399. (Pubitemid 36287681)
147. Takehara N, Makita N, Kawabe J, Sato N, Kawamura Y, Kitabatake A, Kikuchi K. 2004. A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med 255:137-142. (Pubitemid 38121933)
148. Takimoto K, Li D, Nerbonne JM, Levitan ES. 1997. Distribution, splicing and glucocorticoid-induced expression of cardiac alpha 1C and alpha 1D voltage-gated Ca2+ channel mRNAs. J Mol Cell Cardiol 29:3035-3042. (Pubitemid 27510770)
149. Tan HL, Bink-Boelkens MT, Bezzina CR, Viswanathan PC, Beaufort-Krol GC, van Tintelen PJ, van den Berg MP, Wilde AA, Balser JR. 2001. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 409:1043-1047.
150. 2+ channels to chromosomes 10p12 and 2q22-q23. Hum Genet 100:151-154.
151. Tester DJ, Ackerman MJ. 2006. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 21:166-172. (Pubitemid 44315078)
152. Tester DJ, Will ML, Haglund CM, Ackerman MJ. 2005. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2:507-517. (Pubitemid 40521365)
153. Tfelt-Hansen J, Jespersen T, Hofman-Bang J, Rasmussen HB, Cedergreen P, Skovby F, Abriel H, Svendsen JH, Olesen SP, Christiansen M, Haunso S. 2009. Ventricular tachycardia in a Brugada syndrome patient caused by a novel deletion in SCN5A. Can J Cardiol 25:156-160.
154. Tian L, Zhu JF, Yang JG. 2007. [Gene (SCN5A) mutation analysis of a Chinese family with Brugada syndrome]. Zhonghua Xin Xue Guan Bing Za Zhi 35:1122-1125.
155. Van PF, Clark KA, Chatelain FC, Minor Jr DL. 2004. Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain. Nature 429:671-675.
156. Van Norstrand DW, Valdivia CR, Tester DJ, Ueda K, London B, Makielski JC, Ackerman MJ. 2007. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 116:2253-2259. (Pubitemid 350100330)
157. Vatta M, Dumaine R, Antzelevitch C, Brugada R, Li H, Bowles NE, Nademanee K, Brugada J, Brugada P, Towbin JA. 2002a. Novel mutations in domain I of SCN5A cause Brugada syndrome. Mol Genet Metab 75:317-324. (Pubitemid 34971581)
158. Vatta M, Dumaine R, Varghese G, Richard TA, Shimizu W, Aihara N, Nademanee K, Brugada R, Brugada J, Veerakul G, Li H, Bowles NE, Brugada P, Antzelevitch C, Towbin JA. 2002b. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 11:337-345. (Pubitemid 34173363)
159. Veltmann C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F, Spehl S, Borggrefe M, Wolpert C. 2006. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 27:2544-2552. (Pubitemid 44627298)
160. Vernooy K, Sicouri S, Dumaine R, Hong K, Oliva A, Burashnikov E, Timmermans C, Delhaas T, Crijns HJGM, Antzelevitch C, Rodriguez L-M, Brugada R. 2006. Heart Rhythm 3:1074-1078.
161. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F, Dolphin AC. 2004. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci 7:939-946. (Pubitemid 39129502)
162. Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. 2009. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. Heart Rhythm 6:401-404.
163. Wang DW, Desai RR, Crotti L, Arnestad M, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Rognum T, Schwartz PJ, George Jr AL. 2007. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 115:368-376. (Pubitemid 46148511)
164. Wang K, Yamauchi K, Li P, Kato H, Kobayashi M, Kato K, Shimizu Y. 2008. Costeffectiveness of implantable cardioverter-defibrillators in Brugada syndrome treatment. J Med Syst 32:51-57.
165. Wang Q, Li Z, Shen J, Keating MT. 1996. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 34:9-16. (Pubitemid 26159876)
166. Wang Q, Shen J, Li Z, Timothy K, Vincent GM, Priori SG, Schwartz PJ, Keating MT. 1995. Cardiac sodium channel mutations in patients with long QTsyndrome, an inherited cardiac arrhythmia. Hum Mol Genet 4:1603-1607.
167. Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, Schott J-J, Demolombe S, Probst V, Anselme F, Escande D, Wiesfeld ACP, Pfeufer A, Kaab S, Wichmann H-E, Hasdemir C, Aizawa Y, Wilde AAM, Roden DM, Bezzina CR. 2008. Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 118:2260-2268. (Pubitemid 351872343)
168. Weiss R, Barmada MM, Nguyen T, Seibel JS, Cavlovich D, Kornblit CA, Angelilli A, Villanueva F, McNamara DM, London B. 2002. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation 105:707-713. (Pubitemid 34157374)
169. Wichter T, Matheja P, Eckardt L, Kies P, Schafers K, Schulze-Bahr E, Haverkamp W, Borggrefe M, Schober O, Breithardt G, Schafers M. 2002. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 105:702-706. (Pubitemid 34157373)
170. Yamakawa Y, Ishikawa T, Uchino K, Mochida Y, Ebina T, Sumita S, Kobayashi T, Matsushita K, Matsumoto K, Ohkusu Y, Nishizawa T, Takigiku K, Iwamoto M, Kimura K, Umemura S. 2004. Prevalence of right bundle-branch block and right precordial ST-segment elevation (Brugada-type electrocardiogram) in Japanese children. Circ J 68:275-279. (Pubitemid 38470697)
171. Yan GX, Antzelevitch C. 1999. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100:1660-1666. (Pubitemid 29477277)
172. Yang N, George Jr AL, Horn R. 1996. Molecular basis of charge movement in voltagegated sodium channels. Neuron 16:113-122. (Pubitemid 26044734)
173. Yokoi H, Makita N, Sasaki K, Takagi Y, Okumura Y, Nishino T, Makiyama T, Kitabatake A, Horie M, Watanabe I, Tsutsui H. 2005. Double SCN5A mutation underlying asymptomatic Brugada syndrome. Heart Rhythm 2:285-292. (Pubitemid 40309827)
174. Yu H, Wu J, Potapova I, Wymore RT, Holmes B, Zuckerman J, Pan Z, Wang H, Shi W, Robinson RB, El-Maghrabi MR, Benjamin W, Dixon J, McKinnon D, Cohen IS, Wymore R. 2001. MinK-related peptide 1: a beta subunit for the HCN ion channel subunit family enhances expression and speeds activation. Circ Res 88:E84-E87.
175. Zhang M, Jiang M, Tseng GN. 2001. minK-related peptide 1 associates with Kv4.2 and modulates its gating function: potential role as beta subunit of cardiac transient outward channel? Circ Res 88:1012-1019.